Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature

Background: Diabetic retinopathy (DR) is the leading cause of blindness in the working-age population. The purpose of this review is to gather the existing literature regarding the use of the approved anti-vascular endothelial growth (anti-VEGF) agents in the treatment of DR. Methods: A comprehensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatziralli, Irini, Loewenstein, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399287/
https://www.ncbi.nlm.nih.gov/pubmed/34452097
http://dx.doi.org/10.3390/pharmaceutics13081137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399287/
https://www.ncbi.nlm.nih.gov/pubmed/34452097
http://dx.doi.org/10.3390/pharmaceutics13081137

Ejemplares similares